Autolus Therapeutics PLC
NASDAQ:AUTL

Watchlist Manager
Autolus Therapeutics PLC Logo
Autolus Therapeutics PLC
NASDAQ:AUTL
Watchlist
Price: 2.18 USD -4.8% Market Closed
Market Cap: 580.1m USD
Have any thoughts about
Autolus Therapeutics PLC?
Write Note

EV/FCFF
Enterprise Value to FCFF

-0.8
Current
-3.9
Median
3.9
Industry
Higher than median
Lower than industry value

Enterprise Value to Free Cash Flow To Firm (EV/FCFF) ratio is a valuation multiple that compares the value of a company, debt included, to the amount of free cash flow available for all stakeholders. This metric is very similar to the EV/OCF but is considered a more exact measure, owing to the fact that it uses free cash flow, which subtracts capital expenditures (CapEx) from a company's operating cash flow.

EV/FCFF
-0.8
=
Enterprise Value
172m USD
/
FCFF
-205.6m USD
All Countries
Close
Market Cap EV/FCFF
UK
Autolus Therapeutics PLC
NASDAQ:AUTL
580.1m USD -0.8
FR
Pharnext SCA
OTC:PNEXF
6T USD -239 090.7
US
Abbvie Inc
NYSE:ABBV
315.2B USD 23.5
US
Amgen Inc
NASDAQ:AMGN
141.9B USD 30.2
US
Gilead Sciences Inc
NASDAQ:GILD
116.4B USD 11.1
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
104.5B USD -71.6
US
Epizyme Inc
F:EPE
94.1B EUR -469.1
AU
CSL Ltd
ASX:CSL
135.7B AUD 62.7
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
78.7B USD 21.6
US
Seagen Inc
F:SGT
39.3B EUR -56.6
NL
argenx SE
XBRU:ARGX
36B EUR -104.4
 
UK
Autolus Therapeutics PLC
NASDAQ:AUTL
Average EV/FCFF: 29.8
Negative Multiple: -0.8
FR
Pharnext SCA
OTC:PNEXF
Negative Multiple: -239 090.7
US
Abbvie Inc
NYSE:ABBV
23.5
US
Amgen Inc
NASDAQ:AMGN
30.2
US
Gilead Sciences Inc
NASDAQ:GILD
11.1
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
Negative Multiple: -71.6
US
E
Epizyme Inc
F:EPE
Negative Multiple: -469.1
AU
CSL Ltd
ASX:CSL
62.7
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
21.6
US
S
Seagen Inc
F:SGT
Negative Multiple: -56.6
NL
argenx SE
XBRU:ARGX
Negative Multiple: -104.4

EV/FCFF Forward Multiples

Forward EV/FCFF multiple is a version of the EV/FCFF ratio that uses forecasted free cash flow to firm for the EV/FCFF calculation. 1-Year, 2-Years, and 3-Years forwards use free cash flow to firm forecasts for 1, 2, and 3 years ahead, respectively.

1-Year Forward
EV/FCFF
N/A
2-Years Forward
EV/FCFF
N/A
3-Years Forward
EV/FCFF
N/A

See Also

Discover More